Works matching IS 15257304 AND DT 2024 AND VI 25 AND IP 3

Results: 10
    1

    A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 266, doi. 10.1016/j.cllc.2024.03.003
    By:
    • Garon, Edward B.;
    • Byoung Chul Cho;
    • Luft, Alexander;
    • Alatorre-Alexander, Jorge;
    • Geater, Sarayut Lucien;
    • Dmytro Trukhin;
    • Sang-We Kim;
    • Ursol, Grygorii;
    • Hussein, Maen;
    • Louise Lim, Farah;
    • Cheng-Ta Yang;
    • Araujo, Luiz Henrique;
    • Haruhiro Saito;
    • Reinmuth, Niels;
    • Kohlmann, Milena;
    • Lowery, Caitlin;
    • Mann, Helen;
    • Peters, Solange;
    • Mok, Tony S.;
    • Johnson, Melissa L.
    Publication type:
    Article
    2

    Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 233, doi. 10.1016/j.cllc.2023.11.007
    By:
    • Riudavets, Mariona;
    • Auclin, Edouard;
    • Mosteiro, Miguel;
    • Dempsey, Naomi;
    • Majem, Margarita;
    • Prelaj, Arsela;
    • López-Castro, Rafael;
    • Bosch-Barrera, Joaquim;
    • Pilotto, Sara;
    • Escalera, Elena;
    • Tagliamento, Marco;
    • Mosquera, Joaquin;
    • Zalcman, Gérard;
    • Nana, Frank Aboubakar;
    • Ponce, Santiago;
    • Albarrán-Artahona, Víctor;
    • Maso, Alessandro Dal;
    • Spotti, Martina;
    • Mielgo, Xabier;
    • Mussat, Elodie
    Publication type:
    Article
    3
    4
    5

    STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 274, doi. 10.1016/j.cllc.2023.12.010
    By:
    • Rodriguez-Abreu, Delvys;
    • Bosch-Barrera, Joaquim;
    • Gray, Jhanelle E.;
    • Myung-Ju Ahn;
    • Johnson, Melissa;
    • Xinwei Yu;
    • Mohammad, Saad;
    • Xueying Chen;
    • Todd, Trever;
    • Jongseok Kim;
    • Reck, Martin
    Publication type:
    Article
    6
    7

    Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 262, doi. 10.1016/j.cllc.2024.03.002
    By:
    • Marmarelis, Melina E.;
    • Scholes, Dylan G.;
    • McGrath, Cindy M.;
    • Priore, Salvatore F.;
    • Roth, Jacquelyn J.;
    • Feldman, Michael;
    • Morrissette, Jennifer J. D.;
    • Litzky, Leslie;
    • Deshpande, Charu;
    • Thompson, Jeffrey C.;
    • Doucette, Abigail;
    • Gabriel, Peter E.;
    • Sun, Lova;
    • Singh, Aditi P.;
    • Cohen, Roger B.;
    • Langer, Corey J.;
    • Carpenter, Erica L.;
    • Aggarwal, Charu
    Publication type:
    Article
    8
    9

    Lung Cancer Survival Trends in the Veterans Health Administration.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 225, doi. 10.1016/j.cllc.2024.02.009
    By:
    • Moghanaki, Drew;
    • Taylor, James;
    • Bryant, Alex K.;
    • Vitzthum, Lucas K.;
    • Sebastian, Nikhil;
    • Gutman, David;
    • Burns, Abigail;
    • Zhonglu Huang;
    • Lewis, Jennifer A.;
    • Spalluto, Lucy B.;
    • Williams, Christina D.;
    • Sullivan, Donald R.;
    • Slatore, Christopher G.;
    • Behera, Madhusmita;
    • Stokes, William A.
    Publication type:
    Article
    10